BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 30, 2008
View Archived Issues
Kosan's Cancer Pipeline Attracts $5.50 Per Share BMS Buyout Bid
Kosan Biosciences Inc. is being snatched up by Bristol-Myers Squibb Co. for $5.50 per share, becoming the latest acquisition as big pharma struggles to fill dwindling pipelines. (BioWorld Today)
Read More
FDA Documents Critical of Ligand's Promacta
Read More
Onconase Misses Endpoint, Rolling NDA to Proceed
Read More
NewCo News: EnzymeRx Makes a $14 Million Start with Uricase Acquisition
Read More
Drug Labeling Rule Proposed for Those Pregnant, Breastfeeding
Read More
Favrille Laying Off 132 After Specifid Fails Pivotal Trial
Read More
Other News To Note
Read More
Clinic Roundup
Read More